Preterm Birth and PROM Testing Market by Test Type (Preterm Birth Tests, PROM Tests), End-User (Hospitals, Diagnostics Laboratories), & Region for 2024-2031

Preterm Birth and PROM Testing Market Valuation – 2024-2031

The preterm birth and PROM (Premature Rupture of Membranes) testing market focuses on the diagnosis and treatment of early births and membrane rupture. The growth is being driven by rising preterm birth rates and advances in diagnostic technologies. Emerging markets are growing as people become more aware of the importance of healthcare. This is likely to enable the market size to surpass USD 2.39 Billion in 2024 to reach a valuation of around USD 4.11 Billion by 2031.

Leading manufacturers in this market are developing novel tests for early detection and management. Non-invasive procedures and point-of-care diagnostics are defining the future. Demand for precise, quick findings drives market growth as healthcare professionals strive to improve patient outcomes and prevent preterm birth problems. The rising demand for Preterm Birth and Prom Testing is enabling the market grow at a CAGR of 7.76% from 2024 to 2031.

Preterm Birth and PROM Testing MarketDefinition/ Overview

Preterm birth is defined as a delivery occurring before 37 weeks of pregnancy, which may result in health complications for the baby. PROM Testing Evaluation for Premature Rupture of Membranes (PROM), in which the amniotic sac ruptures before labor begins, assesses risks and guides management to avoid difficulties for both mother and baby.

Preterm birth and PROM (preterm rupture of membranes) testing aid in detecting high-risk pregnancies. Preterm birth testing determines the possibility of early labor, whereas PROM testing detects membrane rupture, which helps to prevent infections and manage preterm delivery risks. Both are critical for early intervention and better infant outcomes.

Future applications of preterm birth and PROM (Premature Rupture of Membranes) testing include increasing early detection, guiding targeted therapies and personalizing treatment approaches. To minimize preterm birth rates and related difficulties, advances will be made by combining predictive biomarkers, establishing non-invasive diagnostic procedures and revising clinical guidelines.

Will Increasing Prevalence of Preterm Births Boost the Preterm Birth and PROM Testing Market Growth?

The rising occurrence of premature births will drive the preterm birth and PROM testing industry. In 2021, the U.S. preterm birth rate increasing to 10.5%, up from 10.1% in 2020, with almost one in every ten babies born preterm. Between 2014 and 2021, the rate climbed by 12%, with roughly 15 million babies born preterm around the world each year.

PROM complicates 2-3% of pregnancies in the United States and is connected with 30-40% of premature births, emphasizing the importance of appropriate diagnostic solutions. This rising incidence highlights the need for new diagnostic tools and interventions, which are driving market expansion as healthcare practitioners strive to effectively manage and reduce the occurrence of preterm births and related consequences.

Will High Cost of Testing Hamper the Preterm Birth and PROM Testing Market?

The high cost of testing may limit the preterm birth and PROM testing market to some extent. Testing costs, which are influenced by advanced technologies and healthcare facilities, can be a considerable barrier, especially in low-resource nations.

In the United States, for example, handling premature births incurs significant costs, with each case costing $65,000 and adding to a $26.2 billion yearly burden on the healthcare system. This hefty expense may dissuade some healthcare practitioners and patients from seeking advanced testing. However, it may increase demand for more economical, cost-effective testing methods and innovations in the marketplace. Efforts to lower costs and enhance accessibility could help to offset these issues while also supporting overall industry growth.

Category-Wise Acumens

Will Increasing Effectiveness in Monitoring Fetal and Uterine Health Drive the Test Type Segment?

Increasing efficacy in monitoring fetal and uterine health will drive the test type sector. Advances in technologies such as ultrasound and biomarker tests improve diagnostic accuracy, enabling for more effective care of preterm deliveries and PROM complications. Enhanced ultrasound capabilities offer more detailed images and insights into fetal development and uterine problems, resulting in better early identification and intervention techniques.

Similarly, advances in biomarker testing enable more exact identification of risk factors and illnesses. As these technologies improve in effectiveness, they are likely to gain traction and drive market expansion. The capacity to better monitor and manage pregnancy issues will result in increasing demand for advanced testing solutions, propelling the test type sector forward. 

Will Increasing Wide Range of Diagnostic Tests and Immediate Clinical Interventions Drive the End-User Segment?

The growing number of diagnostic tests and the capacity to deliver quick clinical treatments will propel the end-user segment. Hospitals are well-positioned to profit from advances in diagnostic technologies because of their comprehensive care infrastructure, which includes access to a variety of diagnostic tests and specialists.

Hospitals are the recommended site for these services because they can perform a wide range of diagnostics, such as ultrasounds and biomarker assessments, as well as respond rapidly to preterm birth and PROM complications. As diagnostic capabilities improve and clinical interventions become more advanced, hospitals will continue to increase their use of preterm birth and PROM testing. This trend will continue to boost the end-user segment, cementing hospitals’ dominance in this market.

Gain Access into Preterm Birth and Prom Testing Market Report Methodology

Country/Region-wise Acumens

Will Advanced Healthcare Infrastructure Drive the Market in North America?

Advanced healthcare infrastructure will fuel the market in North America, enabling the region hold major share. According to the US Department of Health and Human Services, by 2020, 96% of non-federal acute care hospitals will have implemented certified electronic health records (EHRs). Additionally, 76% of U.S. hospitals used telemedicine technologies, such as video consultations, to improve patient care and access to services.

This solid infrastructure enables the effective deployment and maintenance of modern diagnostic tests for preterm delivery and PROM. The combination of EHRs and telemedicine enhances data management, diagnostic accuracy and allows for rapid treatments. These technological developments not only improve clinical capabilities, but also promote adoption of testing solutions, resulting in market growth in North America.

Will Increasing Healthcare Investments Drive the Market in Asia Pacific Region?

The Asia Pacific region is expected to exhibit rapid growth in the preterm birth and premature rupture of membranes (PROM) testing market due to increase in healthcare investments. This growth is primarily owing to improvement in healthcare infrastructure which results in better-equipped hospitals and clinics with advanced medical technologies, enhancing the capacity for more sophisticated prenatal care and diagnostic services. Thus, access to advanced diagnostic tools improves the accuracy and timeliness of diagnoses, leading to better outcomes for mothers and infants.Aso, providing better training and education for healthcare professionals results in improved prenatal care and reduced incidence of preterm births and PROM. In response to the need for improvement in prenatal care, there is high demand for research and development activities in diagnostic tests and treatments, such as new biomarkers or non-invasive tests.

Public health campaigns can raise awareness about the risks of preterm birth and the importance of prenatal care, leading to earlier detection and prevention strategies. Expanding healthcare coverage can make prenatal testing more accessible and affordable for a larger population, increasing the usage of PROM and preterm birth testing services.

The implementation of maternal health programs is projected to facilitate the integration of preterm birth and PROM testing into broader maternal and child health programs, leading to better preventive care and management strategies.

Furthermore, increasing healthcare investments in the Asia Pacific region are expected to significantly boost the market for preterm birth and PROM testing, improving healthcare outcomes for mothers and babies while reducing long-term healthcare costs.

Competitive Landscape

The preterm birth and PROM testing market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the preterm birth and prom testing market include

• Qiagen N.V.
• Hologic, Inc.
• Cooper Surgical, Inc.
• Abbott
• Medixbiochemica
• Sera Prognostics
• Clinical Innovations, LLC
• Biosynex
• NX Prenatal, Inc.
• 1Q Products

Latest Developments

• In May 2022, Sera Prognostics and the Newborn Foundation launched the Every Mother, Every Baby project. The purpose is to educate physicians, policymakers and public health stakeholders on the importance of validated biomarker-based preterm risk assessment tests, such as Sera’s PreTRM test, in improving neonatal health outcomes maternal health outcomes.
• In November 2021, Sera Prognostics has partnered with PreemieWorld, GLO Preemies and the Alliance for Black NICU Families to empower and support families affected by preterm birth.

Report Scope

Preterm Birth and Prom Testing Market, By Category

Test Type

• Preterm Birth Tests
  • Pelvic Exam
  • Ultrasound
  • Uterine Monitoring
  • Biomarker
• PROM Tests
  • Nitrazine Test
  • Ferning Test
  • Pooling
  • Ultrasound
  • Fetal Fibronectin Test
  • Biomarker Test

End-User

• Hospitals
• Diagnostics Laboratories

Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.